Showing 9,181 - 9,200 results of 224,509 for search '(( a ((a decrease) OR (linear decrease)) ) OR ( a ((greatest decrease) OR (largest decrease)) ))', query time: 1.24s Refine Results
  1. 9181
  2. 9182
  3. 9183

    Assessment of antioxidative capacity and ROS in HK-2 cells following molybdenum treatment and H<sub>2</sub>O<sub>2</sub>-induced oxidative stress. by Joo Hong Joun (19287602)

    Published 2024
    “…<p>(A) A viability assay was performed to determine the cytotoxic extent of molybdenum on HK-2 cells. …”
  4. 9184

    Supplementary Material for: Topo-Proteomic in situ Analysis of Psoriatic Plaque under Efalizumab Treatment by Bonnekoh B. (4106116)

    Published 2007
    “…At the ‘EfaBS-centered, double colocation level’ a corresponding decrease was observed for CD2, CD3, CD4, CD8, CD11a, CD13, CD26, CD44, CD45, CD45R0, CD54, CD62L, HLA-DR, and TIA-1. …”
  5. 9185
  6. 9186
  7. 9187
  8. 9188
  9. 9189
  10. 9190
  11. 9191

    S1 Dataset - by Joo Hong Joun (19287602)

    Published 2024
    “…In the adult NHANES population, urinary molybdenum-to-creatinine ratio was significantly associated with decreased serum uric acid (β, -0.119; 95% CI, -0.148 to -0.090) concentrations, and decreased prevalence of hyperuricemia (OR, 0.73; 95% CI, 0.64–0.83) and gout (OR, 0.71; 95% CI, 0.52–0.94). …”
  12. 9192
  13. 9193
  14. 9194
  15. 9195
  16. 9196
  17. 9197
  18. 9198
  19. 9199

    Deuterium uptake profiles (data points) and maximum-entropy fits (smooth curves [54]) vs. H/D exchange period (log<sub>10</sub> scale) for selected segments of free and complexed A... by Yeqing Tao (4348336)

    Published 2017
    “…<p>Segment 91–96 of putative binding Interface I exhibits a significant decrease in D-uptake upon forming the complex. …”
  20. 9200